| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Certification: | GMP, ISO 9001, USP, BP |
| Suitable for: | Elderly, Adult, Animal |
| State: | Solid |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Veterinary Raw Material Enrofloxacin Sodium CAS266346-15-0 raw powder 99% Enrofloxacin Sodium
| Common Name | Enrofloxacin Sodium | ||
|---|---|---|---|
| CAS Number | 266346-15-0 | Molecular Weight | 381.376 |
| Density | N/A | Boiling Point | N/A |
| Molecular Formula | C19H21FN3NaO3 | Melting Point | N/A |
| Items | Specifications | Results |
| Character | White or almost white crystalline powder;odorless | white crystelline powder, odorless |
| Melting point | 242~246°C | 243.4~244.3°C |
| Identification | 1) IR spectra is consistent with CRS | complies |
| 2) The retention time of the major peak in the chromatogram of the assay preparation corresponds to that in the chromatogram of the standard preparation, as obtained in the assay | complies | |
| Appearance of solution | colorless and clear liquid | colorless and clear liquid |
| Related substances | individual impurity≤1.0% | 0.24% |
| Total impuirties ≤2.0% | 0.70% | |
| Loss on ignition | ≤0.5% | 0.32% |
| Residue on ignition | ≤0.1% | 0.05% |
| Heavy metals | Not more than 10 parts per million | Less than 10 parts per million |
| Assay | Not less than 98.0% of C18H14F3N3O6S(On dried basis) | 99.40% |
| Conclusion: | Complies with Ponazuril Enterprise Standard | |
Enrofloxacin (ENR) is a fluoroquinolone antibiotic .
It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration-dependent, with susceptible bacteria cell death occurring within 20-30 minutes of exposure. Enrofloxacin has demonstrated a significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication.
Enrofloxacin is a synthetic antibacterial agent from the class of the fluoroquinolone carboxylic acid derivatives. It has antibacterial activity against a broad spectrum of Gram-negative and Gram-positive bacteria. Its mechanism of action is not thoroughly understood, but it is believed to act by inhibiting bacterial DNA gyrase(a type-II topoisomerase), thereby preventing DNA supercoiling and DNA synthesis.
1. Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the of choice.
2. Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the of choice.
3. Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the of choice.
| Product Name | CAS No. | Product Name | CAS No. |
| Lufenuron | 103055-07-8 | Toltrazuril | 69004-03-1 |
| Nitenpyram | 120738-89-8 | Praziquantel/Biltricide | 55268-74-1 |
| Fenbendazole | 43210-67-9 | Tetramisole Hcl | 5086-74-8 |
| Levamisole | 14769-73-4 | Ponazuril | 9004-4-2 |
| Diclazuril | 101831-37-2 | Florfenicol | 73231-34-2 |
| Ivermectin | 70288-86-7 | Enrofloxacin Hcl | 112732-17-9 |
| Albendazole | 54965-21-8 | Mebendazole | 31431-39-7 |
Xi'an Biohorlden Industry&Trade Co.,Ltd is a national key high-tech enterprise,which mainly specializes in the R&D, operation and production of pharmaceuticals,and intermediates.Our company is situated in E&T development zone,xi'an city shaanxi,it is easy of access. Our company has independent R&D center,raw material synthesis workshop, has advanced quality instruments and equipmentm,several product patents there are 15 experts in our research team.We insist in innovation and produce high quality products.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}